Home » Topics » BioWorld Science

BioWorld Science
RSS

GPR171 agonism ameliorates chronic neuropathic and inflammatory pain

April 8, 2022

New Fgf1a murine models of heart failure and metabolic syndrome developed

April 8, 2022

Soltego discloses new SIK inhibitors

April 8, 2022

Medshine Discovery patents AKR1C3 inhibitors

April 8, 2022

Cadila Healthcare discloses new ACP1 inhibitors

April 8, 2022

Seoul Techno Holdings identifies new compounds for cancer

April 8, 2022

Elastrin Therapeutics closes funding round to advance development of lead candidate

April 8, 2022

1st Bio Therapeutics presents new protein kinase inhibitors

April 8, 2022

Novel HlyU inhibitor VM-17 attenuates the virulence of V. vulnificus

April 8, 2022

Researchers in China find evidence in mice that bacteria in tumors help cancer cells metastasize

April 8, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...